fda largenotapprovedstamp

FDA defends CRISPR-edited animal rules likely to block most uses: Is the agency trying to avoid litigation from anti-GMO groups?

"How can the presence of one identifiable variant justify the costs and delays of mandatory FDA oversight?" ...
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.